These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31383301)

  • 1. Immunoproteomic characterization of outer membrane vesicles from hyper-vesiculating Actinobacillus pleuropneumoniae.
    Antenucci F; Magnowska Z; Nimtz M; Roesch C; Jänsch L; Bojesen AM
    Vet Microbiol; 2019 Aug; 235():188-194. PubMed ID: 31383301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outer Membrane Vesicles of Actinobacillus pleuropneumoniae Exert Immunomodulatory Effects on Porcine Alveolar Macrophages.
    Zhu Z; Antenucci F; Winther-Larsen HC; Skovgaard K; Bojesen AM
    Microbiol Spectr; 2022 Oct; 10(5):e0181922. PubMed ID: 36040198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of a common 48-kilodalton outer membrane protein of Actinobacillus pleuropneumoniae.
    Cruz WT; Nedialkov YA; Thacker BJ; Mulks MH
    Infect Immun; 1996 Jan; 64(1):83-90. PubMed ID: 8557378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo testing of novel vaccine prototypes against Actinobacillus pleuropneumoniae.
    Antenucci F; Fougeroux C; Deeney A; Ørskov C; Rycroft A; Holst PJ; Bojesen AM
    Vet Res; 2018 Jan; 49(1):4. PubMed ID: 29316978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoproteomic analysis of outer membrane proteins and extracellular proteins of Actinobacillus pleuropneumoniae JL03 serotype 3.
    Liao Y; Deng J; Zhang A; Zhou M; Hu Y; Chen H; Jin M
    BMC Microbiol; 2009 Aug; 9():172. PubMed ID: 19695095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of serovar-independent immunogens in Actinobacillus pleuropneumoniae.
    Antenucci F; Fougeroux C; Bossé JT; Magnowska Z; Roesch C; Langford P; Holst PJ; Bojesen AM
    Vet Res; 2017 Nov; 48(1):74. PubMed ID: 29122004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of conserved surface proteins as novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae.
    Chen X; Xu Z; Li L; Chen H; Zhou R
    J Microbiol; 2012 Dec; 50(6):978-86. PubMed ID: 23274984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Actinobacillus pleuropneumoniae surface polysaccharides: their role in diagnosis and immunogenicity.
    Dubreuil JD; Jacques M; Mittal KR; Gottschalk M
    Anim Health Res Rev; 2000 Dec; 1(2):73-93. PubMed ID: 11708600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New trends in innovative vaccine development against Actinobacillus pleuropneumoniae.
    Loera-Muro A; Angulo C
    Vet Microbiol; 2018 Apr; 217():66-75. PubMed ID: 29615259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and characterization of a gene encoding an antigenic membrane protein from Actinobacillus pleuropneumoniae with homology to ABC transporters.
    Martin PR; Mulks MH
    FEMS Immunol Med Microbiol; 1999 Aug; 25(3):245-54. PubMed ID: 10459579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs.
    van den Bosch H; Frey J
    Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Quan K; Zhu Z; Cao S; Zhang F; Miao C; Wen X; Huang X; Wen Y; Wu R; Yan Q; Huang Y; Ma X; Han X; Zhao Q
    J Microbiol Biotechnol; 2018 Dec; 28(12):2095-2105. PubMed ID: 30380823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AasP autotransporter protein of Actinobacillus pleuropneumoniae does not protect pigs against homologous challenge.
    Oldfield NJ; Worrall KE; Rycroft AN; Ali T; Wooldridge KG; Ala'Aldeen DA
    Vaccine; 2009 Aug; 27(38):5278-83. PubMed ID: 19563888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virulence factors of the swine pathogen Actinobacillus pleuropneumoniae.
    Tascón RI; Vázquez-Boland JA; Gutiérrez-Martín CB; Rodríguez-Barbosa JI; Rodríguez-Ferri EF
    Microbiologia; 1996 Jun; 12(2):171-84. PubMed ID: 8767702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and characterization of novel antigenic vaccine candidates of Actinobacillus pleuropneumoniae.
    Oldfield NJ; Donovan EA; Worrall KE; Wooldridge KG; Langford PR; Rycroft AN; Ala'Aldeen DA
    Vaccine; 2008 Apr; 26(16):1942-54. PubMed ID: 18342410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection.
    Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF
    Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic differences within Actinobacillus pleuropneumoniae serotype 1.
    Jolie RA; Mulks MH; Thacker BJ
    Vet Microbiol; 1994 Feb; 38(4):329-49. PubMed ID: 8160348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of pig lungs following an experimental challenge with Actinobacillus pleuropneumoniae serotype 1 and 5 in pigs inoculated with either hemolysin protein and/or outer membrane proteins.
    Madsen ME; Carnahan KG; Thwaits RN
    FEMS Microbiol Lett; 1995 Sep; 131(3):329-35. PubMed ID: 7557344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of the third antigenically distinct outer membrane lipoprotein (OmlA) in Actinobacillus pleuropneumoniae serotype 7.
    Ito H; Osaki M; Uchida I; Ohya T; Sekizaki T
    FEMS Microbiol Lett; 1998 Oct; 167(2):303-8. PubMed ID: 9809431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of proteins of Propionibacterium acnes for use as vaccine candidates to prevent infection by the pig pathogen Actinobacillus pleuropneumoniae.
    Li L; Sun C; Yang F; Yang S; Feng X; Gu J; Han W; Langford PR; Lei L
    Vaccine; 2013 Oct; 31(45):5269-75. PubMed ID: 24051157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.